Malignant pheochromocytoma - Progress in diagnosis and therapy;Pheochromocytoma malignum - Postȩpy w rozpoznawaniu i leczeniu

Polskie Archiwum Medycyny Wewnetrznej

Volumn 96, Issue 1, 1996, Pages 68-74

  Sworczak, Krzysztof ^a,b   Babińska, Anna ^a  

^a III Kliniki Chorob W AM G ^*

^b III Kliniki Chorob W AM G

Author keywords

Diagnosis; Malignant pheochromocytoma; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADRENAL TUMOR; ADULT; CASE REPORT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PHEOCHROMOCYTOMA; REVIEW;

ADRENAL GLAND NEOPLASMS; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; PHEOCHROMOCYTOMA;

EID: 0030183296     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wajda Z., Szalach E., Sworczak K. i wsp.: Wspótczesne pogla̧dy na rozpoznawanie i leczenie guza chromochłonnego. Pol. Przeg. Chir., 1994, 66, 995.
2. Orlowski T. (red.): Rdzeń nadnerczy. W Nauka o Chorobach Wewnȩtrznych. T. III. PZWL. Warszawa, 1989, 160.
3. Hume D.M.: Pheochromocytoma in the adult and in the child. Am. J. Surg., 1960, 99, 458.
4. Averbuch S.D., Steakley C.S., Young R.C. i wsp.: Malignant pheochromocytoma: effective tratment with a combination of Cyclophosphamide, Vincristine and Dacarbazyne. Ann. Intern. Med., 1988, 109, 267.
5. Wilson J,P,: Pheochromocytoma. In: Harrison's Principles of Internal Medicine. Mc Grew-Hill Inc 1991, 1735.
6. Manger W.M., Gifford R.W.: Pheochromocytoma. Springer-Verlag. New York-Heidelberg-Berlin, 1977.
7. Proye C.A., Vix M., Jansson S., Tisell L.E., Dralle H., Hiller W.: The pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World J. Surg., 1994, 18, 477.
8. Das S., Lowe P.: Malignant pheochromocytoma of the bladder. J. Urol., 1980, 123, 283.
9. Hartwig W.: Choroby rdzenia nadnerczy. W: Endokrynologia praktyczna PZWL, Warszawa, 1989, 225.
10. Modlin M., Fardon J.R., Shepherd A. i wsp.: Pheochromocytoma in 72 patients: clinical and diagnosis futures, treatment and long term results. Brit. J. Surg., 1979, 66, 457.
11. Werbel S.S., Ober K.P.: Pheochromocytoma: update on diagnosis, localization and management. Med. Clin. North Am., 1995, 79, 131.
12. Shapiro B., Sisson J.C., Loyd R., Nakajo M., Satterlee W., Beierwaltes W.H.: Malignant pheochromocytoma: clinical, biochemical and scintigraphic charakterization. Clin. Endocrinol. Oxf., 1984, 20, 189.
13. Hoffman K., Gil J., Barba J. i wsp.: Morphometric analysis of bening and malignant adrenal pheochromocytoma. Arch. Pathol. Lab. Med., 1993, 117, 244.
14. Cuerda C., Castejon J., Astigarraga B. i wsp.: A malignant extraadrenal pheochromocytoma. A propos 2 cases. Rev. Clin. Esp., 1993, 192, 76.
15. Short J.A., Podfield P.L.. Malignant pheochromocytoma with severe constipation and myocardial necrosis. Brit. Med. J., 1976, 2, 793.
16. Henry D.P., Pratt J.H.: Pheochromocytoma from the biochemical, pharmacokinetic and pathophysiologic point of view. In Endocrine Hypertension ed. Biglieri E.G., Melby J.C., Raven Press Ltd., New York, 1990, 207.
17. Szakacs J.E., Cannon A.: Norepinephrine myocarditis. Am. J. Clin. Pathol., 1985, 30, 425.
18. Val Vliet P.D., Burchel H.B., Titus J.L.: Focal myocarditis associated with pheochromocytoma. N. Engl. J. Med., 1966, 274, 1102.
19. Wiswell J.G., Grago R.M.: Reversible cardiomyopathy with pheochromocytoma. Trans. Am. Clin. Climatol. Assoc., 1968, 80, 185.
20. Januszewicz W.: Pheochromocytoma - postać nadćisnienia z chirurgicznie usuwalna̧ przyczyna̧. Pol. Przeg. Chir. 1992, 64, 1058.
21. Januszewicz W., Wocial B., Sznajderman M.: Guz chromochłonny. PZWL Warszawa 1981.
22. Januszewicz W., Wocial B.: Clinical and biochemical aspects of pheochromocytoma. Cardiology, 1985, 72, 131.
23. Anton A.H., Greer M., Sayre D.F., Williams C.M.: Dihydroxyphenylalanine secretion in a malignant pheochromocytoma. Am. J. Med., 1967, 42, 469.
24. Goldstein D.S., Stull R., Eisenhofer G. i wsp.: Plasma 3,4-dihydroyphenylalanine (DOPA) and catecholamines in neuroblastoma or pheochromocytoma. Ann. Intern. Med., 1986, 105, 887,
25. Oishi S., Sato T.: Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma. Cancer, 1988, 61, 1167.
26. Grouzmann E., Werffeli-George P., Fathi M., Burnier M., Waeber B., Waeber G.: Angiotensin-II mediates norepinephrine and neuropeptide-Y in a human pheochromocytoma. J, Clin. Endocronol. Metab., 1994, 79, 1852.
27. Ahlman H., Jansson S., Wängberg B. i wsp.: Adrenocortical carcinoma - diagnostic and therapeutical implications. Eur. J. Surg., 1993, 159, 149.
28. Maurea S., Cuocolo A., Reynolds J.C. i wsp.: Role of magnetic resonance in the study of bening and malignant pheochromocytoma. Quantitative analysis of the intensity of the resonance signal. Radiol. Med. Torino, 1993, 85, 803.
29. Shapiro B.. Imaging of catecholo-amine-secreting tumours: uses of MIBG in diagnosis and treatment. Baillieres Clin. Endocrinol. Metab., 1993, 7, 491.
30. Shapiro B., Gross M.D., Fig L., Khafagi F : Localization of functioning sympathoadrenal lesions. In Endocrine Hypertension ed. Biglieri E G., Melby J.C. Raven Press ltd., New York, 1990, 235.
31. Dunnick N.R.: Adrenal carcinoma. Radiol. Clin. North. Am., 1994, 32, 99.
32. Moulton J.S.: CT of the adrenal glands. Sem. Roentgenol., 1988, 23, 288.
33. Hussain S., Belldegrun A., Seltzer S.E., Richie J.P., Gittes R.F., Abrams H.L.: Differentation of malignant from bening adrenal masses: predictive indices on computed tomography. Am. J. Radiol., 1985, 144, 61.
34. Lynn M.D., Shapiro B., Sisson J.C.: Portrayal of pheochromocytoma and normal human adrenal medulla by m(I-123) iodemethylquanidine: concise communication. J. Nucl. Med., 1984, 425, 436.
35. Copeland P.M.: The incidentally discovered adrenal mass. Ann. Intern. Med., 1983, 98, 940.
36. Belldegrund A., Hussain S., Seltzer S.E. i wsp.: Incidentally discovered mass of the adrenal gland. Surg. Gynecol. Obstet., 1986, 163, 203.
37. Orth D.N., Kovacs W.J., DeBold C.R.:The adrenal cortex. In: William's Textbook of Endocrinology (red. J.D. Wilson, D.W. Foster) W.B. Sauders, Philadelphia, 1992, 489.
38. 131J-metajodobenzyguanidynydo leczenia złośliwych guzów chromochłonnych z opisem dwóch przypadków. Pol. Tyg. Lek. 1986, 41, 1386.
39. 131J-MIBG)w leczeniu złosliwych guzów chromochłonnych. Probl. Med. Nukl. 1987, 1, 34.
40. Scott H.W., Halter S.A.: Oncologic aspects of pheochromocytoma: the importance of follow-up. Surgery 1984, 94, 1061.
41. Mahoney E.M., Harrison J.H.: Malignant pheochromocytoma: clinical course and treatment. J. Urol. 1977, 118, 225.
42. Przetakiewicz Z., Tolloczko T.: Pheochromocytoma malignum. Pol. Przeg. Chir. 1976, 48, 59.
43. Zieleniewski J., Pruszyński M , Iljin W., Jeżewska-Musial M.: Przypadek złósliwego guza chromochłonnego nadnercza z przerzutami u 51-letniej chorej. Endokrynol. Pol. 1974, 25, 495.